Long term treatment of osteoporosis with anti-resorptive drugs such as bisphosphonates should not be paused because of concerns over rare adverse events such as atypical fractures, a new position statement from Osteoporosis Australia recommends. While some guidelines have suggested that a two year ‘drug holiday’ may be taken after five years of bisphosphonate therapy, the Osteoporosis ...
No drug holidays with bisphosphonates: Osteoporosis Australia
By Michael Woodhead
28 Apr 2020